Blauvelt, A., Jiang, R., Shi, L., Tsoi, L. C., Bogle, R., Fox, J., Gharaee-Kermani, M., Billi, A. C., Matheson, R. T., Photowala, H., Gudjonsson, J. E., Ehst, B. D. (2025). A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab. Nature Communications. https://doi.org/10.1038/s41467-025-67475-0